China SXT Pharmaceuticals (SXTC) Competitors $1.70 +0.14 (+8.97%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.68 -0.02 (-1.47%) As of 08/1/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. MNMD, NAGE, UPB, DAWN, KALV, AMLX, AVBP, MAZE, GYRE, and STOKShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Mind Medicine (MindMed) (MNMD), Niagen Bioscience (NAGE), Upstream Bio (UPB), Day One Biopharmaceuticals (DAWN), KalVista Pharmaceuticals (KALV), Amylyx Pharmaceuticals (AMLX), ArriVent BioPharma (AVBP), Maze Therapeutics (MAZE), Gyre Therapeutics (GYRE), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors Mind Medicine (MindMed) Niagen Bioscience Upstream Bio Day One Biopharmaceuticals KalVista Pharmaceuticals Amylyx Pharmaceuticals ArriVent BioPharma Maze Therapeutics Gyre Therapeutics Stoke Therapeutics Mind Medicine (MindMed) (NASDAQ:MNMD) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends. Do analysts rate MNMD or SXTC? Mind Medicine (MindMed) presently has a consensus target price of $24.00, indicating a potential upside of 184.36%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher probable upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in MNMD or SXTC? 27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. Comparatively, 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. 2.5% of Mind Medicine (MindMed) shares are owned by insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to MNMD or SXTC? In the previous week, Mind Medicine (MindMed) had 7 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 10 mentions for Mind Medicine (MindMed) and 3 mentions for China SXT Pharmaceuticals. China SXT Pharmaceuticals' average media sentiment score of 0.20 beat Mind Medicine (MindMed)'s score of -0.09 indicating that China SXT Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mind Medicine (MindMed) 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral China SXT Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, MNMD or SXTC? Mind Medicine (MindMed) has a beta of 2.49, indicating that its stock price is 149% more volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Which has stronger valuation and earnings, MNMD or SXTC? China SXT Pharmaceuticals has higher revenue and earnings than Mind Medicine (MindMed). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMind Medicine (MindMed)N/AN/A-$108.68M-$1.53-5.52China SXT Pharmaceuticals$1.93M102.20-$3.10MN/AN/A Is MNMD or SXTC more profitable? China SXT Pharmaceuticals' return on equity of 0.00% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Mind Medicine (MindMed)N/A -47.29% -38.29% China SXT Pharmaceuticals N/A N/A N/A SummaryMind Medicine (MindMed) beats China SXT Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$181M$2.46B$5.49B$9.52BDividend YieldN/A1.81%4.73%4.09%P/E RatioN/A8.9728.7823.81Price / Sales102.20437.65372.2066.04Price / CashN/A157.7635.4557.96Price / Book0.014.838.275.54Net Income-$3.10M$31.62M$3.25B$259.28M7 Day Performance6.92%-5.28%-3.70%-4.64%1 Month Performance-4.49%4.38%4.34%4.41%1 Year Performance-80.14%-2.49%25.90%17.95% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.911 of 5 stars$1.70+9.0%N/A-80.3%$181M$1.93M0.0090News CoverageAnalyst UpgradeMNMDMind Medicine (MindMed)1.9119 of 5 stars$9.68-0.8%$24.00+147.9%+0.7%$737.40MN/A-7.5040News CoverageEarnings ReportAnalyst ForecastNAGENiagen Bioscience1.0385 of 5 stars$9.69+4.0%$13.22+36.4%N/A$734.13M$99.60M57.00120Analyst DowngradeUPBUpstream Bio2.0621 of 5 stars$14.34+5.2%$56.50+294.0%N/A$733.21M$2.37M0.0038Upcoming EarningsHigh Trading VolumeDAWNDay One Biopharmaceuticals2.2584 of 5 stars$7.10-1.8%$29.00+308.5%-53.1%$732.85M$131.16M-10.0060Upcoming EarningsKALVKalVista Pharmaceuticals3.8282 of 5 stars$13.57-6.9%$26.29+93.7%-4.5%$728.33MN/A-3.68100AMLXAmylyx Pharmaceuticals2.5321 of 5 stars$7.99-2.0%$11.75+47.1%+272.9%$726.50M$87.37M-2.57200Upcoming EarningsAVBPArriVent BioPharma1.6362 of 5 stars$20.93-1.2%$39.29+87.7%-13.2%$724.62MN/A-5.5540Positive NewsMAZEMaze TherapeuticsN/A$16.36-2.7%$25.60+56.5%N/A$716.52M$167.50M0.00121Lockup ExpirationGYREGyre TherapeuticsN/A$7.81+2.2%N/A-52.4%$716.31M$105.76M390.7040STOKStoke Therapeutics4.0299 of 5 stars$12.81-2.2%$25.80+101.4%-12.3%$715.22M$36.56M16.22100Upcoming Earnings Related Companies and Tools Related Companies Mind Medicine (MindMed) Alternatives Niagen Bioscience Alternatives Upstream Bio Alternatives Day One Biopharmaceuticals Alternatives KalVista Pharmaceuticals Alternatives Amylyx Pharmaceuticals Alternatives ArriVent BioPharma Alternatives Maze Therapeutics Alternatives Gyre Therapeutics Alternatives Stoke Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
